Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%
Market cap
$50.7B
P/E
50.0×
Fwd P/E
26.9×
Dividend yield
—
F-score
7/9
Altman Z
13.57
Beneish M
−2.63
Dividend safety
n/a
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
Piotroski F-Score
5 5 7 7

+8 more TTM periods

ROE
14.42% 13.93% 13.93% 13.72%
ROA
11.90% 11.15% 11.14% 11.83%
ROIC
343.12% 0.00% 87.58% 133.10%
Return on Tangible Assets
15.45% 14.63% 14.13% 13.80%
Average Days of Receivables
59.70 69.03 149.68 44.05
Free Cash Flow per Share
10.09 10.04 8.47 8.24
Free Cash Flow
1,638.77 1,640.21 1,386.09 1,351.10
Capital Expenditures
(26.69) (24.97) (29.13) (26.82)
Other line items
Cash ROIC
11.17% 11.22% 10.06% 9.88%
Accounts Receivable Turnover
6.66 5.68 2.70 9.15
Accounts Payable Turnover
24.90 21.24 22.97 23.24
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
15.17 17.90 17.57 15.91
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.24) (0.24) (0.24) (0.23)
Research and Development Expense of Revenue
23.77% 23.85% 24.02% 24.35%
Selling, General and Administrative Expense of Revenue
21.27% 22.37% 22.83% 23.43%
Share Based Compensation of Revenue
14.30% 14.45% 14.79% 15.25%
Operating CF/Net income
1.64 1.77 1.56 1.60
Depreciation/Fixed assets
0.64 0.65 0.64 0.68
Capex/Depreciation
(0.53) (0.52) (0.65) (0.59)
Revenue per Share
21.30 20.32 19.52 18.78
Operating CF per Share
10.26 10.19 8.65 8.40
Capex per Share
(0.16) (0.15) (0.18) (0.16)
Capex to Sales
0.01 0.01 0.01 0.01

Fold the line items

Columns are period end dates